EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Whole Exome Sequencing and Panel-Based Analysis in 176 Spanish Children with Neurodevelopmental Disorders: Focus on Autism Spectrum Disorder and/or Intellectual Disability/Global Developmental Delay

Ariadna Sánchez Suárez, Beatriz Martínez Menéndez iD, Eduardo Escolar Escamilla, Francisco J Martínez Sarries, Miren Iranzu Esparza Garrido, Belén Gil-Fournier, Soraya Ramiro León, Bárbara Rubio Gribble iD, Juan F Quesada Espinosa iD, Andrés J Alcaraz Romero iD

Genes · 2024

DOI: 10.3390/genes15101310 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Genes, 2024. Verfasst von Ariadna Sánchez Suárez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Escuela Internacional de Doctorado, Rey Juan Carlos University, Alcorcón Campus, 28922 Madrid, Spain. Hauptthemen laut MEDLINE: Exome Sequencing, Autism Spectrum Disorder, Intellectual Disability, Developmental Disabilities. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neurodevelopmental disorders (NDDs) represent a significant challenge in pediatric genetics, often requiring advanced diagnostic tools for the accurate identification of genetic variants.

Objectives

To determine the diagnostic yield of whole exome sequencing (WES) with targeted gene panels in children with neurodevelopmental disorders (NDDs).

Methods

This observational, prospective study included a total of 176 Spanish-speaking pediatric patients with neurodevelopmental disorders (NDDs), encompassing intellectual disability (ID), global developmental delay (GDD), and/or autism spectrum disorder (ASD). Participants were recruited from January 2019 to January 2023 at a University Hospital in Madrid, Spain. Clinical and sociodemographic variables were recorded, along with genetic study results. The age range of the subjects was 9 months to 16 years, and the percentage of males was 72.1%. The diagnostic yield of whole exome sequencing (WES) was calculated both before and after parental testing via Sanger DNA sequencing.

Results

The study included 176 children: 67 (38.1%) with ID, 62 (35.2%) with ASD, and 47 (26.7%) with ASD + ID. The diagnostic yield of proband-only exome sequencing was 12.5% (22/176). By group, the diagnostic yield of proband-only exome sequencing was 3.2% in the ASD, 12.7% in the ASD + ID, and 20.8% in the ID group. Variants of uncertain significance (VUS) were found in 39.8% (70/176). After parental testing, some variants were reclassified as “likely pathogenic”, increasing the diagnostic yield by 4.6%, with an overall diagnostic yield of 17.1%. Diagnostic yield was higher in patients with syndromic ID (70.6%% vs. 29.4%; p = 0.036).

Conclusions

A sequential approach utilizing WES followed by panel-based analysis, starting with the index case and, when appropriate, including the parents, proves to be a cost-effective strategy. WES is particularly suitable for complex conditions, as it allows for the identification of potentially causative genes beyond those covered by targeted panels, providing a more comprehensive analysis. Including parental testing enhances the diagnostic yield and improves accuracy, especially in cases with variants of uncertain significance (VUS), thereby advancing our understanding of NDDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Exome SequencingAutism Spectrum DisorderIntellectual DisabilityDevelopmental DisabilitiesNeurodevelopmental DisordersHumansChildMaleChild, PreschoolFemaleAdolescentSpainInfantProspective StudiesGenetic Testing

Stichwörter der Autor:innen

autism spectrum disorderdiagnostic yieldintellectual disabilityneurodevelopmental disordersvariants of uncertain significancewhole exome sequencing

Autor:innen und Institutionen

  • Escuela Internacional de Doctorado, Rey Juan Carlos University, Alcorcón Campus, 28922 Madrid, Spain.
  • Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Villaviciosa de Odón, 28670 Madrid, Spain.
  • Neurology Department, Getafe University Hospital, 28905 Madrid, Spain.
  • Pediatrics Department, Getafe University Hospital, 28905 Madrid, Spain.
  • Genetics Department, Getafe University Hospital, 28905 Madrid, Spain.
  • Genetics Department, 12 de Octubre University Hospital, 28041 Madrid, Spain.

ORCID-Profile: Beatriz Martínez Menéndez, Bárbara Rubio Gribble, Juan F Quesada Espinosa, Andrés J Alcaraz Romero

Zitieren

APA

Sánchez Suárez, A., Martínez Menéndez, B., Escolar Escamilla, E., Martínez Sarries, F. J., Esparza Garrido, M. I., Gil-Fournier, B., Ramiro León, S., Rubio Gribble, B., Quesada Espinosa, J. F., & Alcaraz Romero, A. J. (2024). Whole Exome Sequencing and Panel-Based Analysis in 176 Spanish Children with Neurodevelopmental Disorders: Focus on Autism Spectrum Disorder and/or Intellectual Disability/Global Developmental Delay. Genes. https://doi.org/10.3390/genes15101310

Vancouver

Sánchez Suárez A, Martínez Menéndez B, Escolar Escamilla E, Martínez Sarries FJ, Esparza Garrido MI, Gil-Fournier B, et al. Whole Exome Sequencing and Panel-Based Analysis in 176 Spanish Children with Neurodevelopmental Disorders: Focus on Autism Spectrum Disorder and/or Intellectual Disability/Global Developmental Delay. Genes. 2024. doi:10.3390/genes15101310

BibTeX
@article{SnchezSurez2024,
  author = {Sánchez Suárez, Ariadna and Martínez Menéndez, Beatriz and Escolar Escamilla, Eduardo and Martínez Sarries, Francisco J and Esparza Garrido, Miren Iranzu and Gil-Fournier, Belén and Ramiro León, Soraya and Rubio Gribble, Bárbara and Quesada Espinosa, Juan F and Alcaraz Romero, Andrés J},
  title = {Whole Exome Sequencing and Panel-Based Analysis in 176 Spanish Children with Neurodevelopmental Disorders: Focus on Autism Spectrum Disorder and/or Intellectual Disability/Global Developmental Delay},
  journal = {Genes},
  year = {2024},
  doi = {10.3390/genes15101310}
}
Kostenlos starten →